Nasdaq: PGEN Russell 2000 Component | |
Industry | Biotechnology |
Founded | May 21, 1998 |
Headquarters | , US |
Revenue | $91 million (2019)[1] |
Number of employees | 600 |
Website | precigen |
Precigen, Inc. (formerly Intrexon Corporation, NASDAQ: PGEN) is an American biotechnology company. Its president and CEO is Helen Sabzevari.
Intrexon was founded in 1998, and is headquartered in Germantown, Maryland.[2][3] With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells.[4]